Nicholas A Froumis, OD
Optometry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Froumis’s office at (408) 972-3413 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Medicaid work
$3,060 in 2024
Medicaid paid $3,060 for 148 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 27 | $1,800 |
| DETERMINATION REFRACTIVE STATE | 121 | $1,260 |
| 2024 | 148 | 2 | 22 | $3,060 |
| 2023 | 131 | 2 | 21 | $152 |
| 2022 | 110 | 3 | 19 | $0 |
| 2021 | 133 | 1 | 19 | $38 |
| 2020 | 56 | 1 | 16 | $0 |
See the largest Medicaid services in earlier years
2023
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 12 | $152 |
| DETERMINATION REFRACTIVE STATE | 119 | $0 |
2022
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 15 | $0 |
| DETERMINATION REFRACTIVE STATE | 82 | $0 |
| Frames, purchases | 13 | $0 |
2021
| DETERMINATION REFRACTIVE STATE | 133 | $38 |
2020
| DETERMINATION REFRACTIVE STATE | 56 | $0 |
Drugs they prescribed that Part D paid
$7,253
Pharmacies billed $7,253 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 112) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
58 generic and 54 brand-name prescriptions · $7,253 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cyclosporine | 13 | $3,935 | $92 |
| Fluorometholone | 12 | $1,344 | $103 |
| Neomycin-Polymyxin-Dexameth | 17 | $280 | $13 |
Year by year
| 2024 | 112 | 59 | 0% (0) | 48% | $7,253 |
| 2023 | 72 | 39 | 0% (0) | 50% | $3,715 |
| 2022 | 63 | 28 | 0% (0) | 40% | $8,411 |
| 2021 | 45 | 27 | 0% (0) | 71% | $14,416 |
| 2020 | 27 | 20 | 0% (0) | 56% | $7,097 |
| 2019 | 15 | None | 0% (0) | None | $5,796 |
| 2018 | 12 | None | 0% (0) | None | $3,327 |
| 2017 | 20 | None | 0% (0) | 70% | $3,527 |
| 2016 | 19 | None | 0% (0) | None | $1,122 |
| 2015 | 16 | None | 0% (0) | None | $1,572 |
| 2014 | 21 | None | 0% (0) | None | $1,450 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Cyclosporine | 24 | $2,401 | $100 |
| Neomycin-Polymyxin-Dexameth | 12 | $150 | $12 |
| Latanoprost | 14 | $118 | $8 |
2022: 3 drugs
| Cyclosporine | 12 | $2,661 | $222 |
| Neomycin-Polymyxin-Dexameth | 16 | $198 | $12 |
| Latanoprost | 15 | $135 | $9 |
2021: 2 drugs
| Restasis | 11 | $7,498 | $682 |
| Cequa | 14 | $6,041 | $431 |
2017: 1 drug
| Latanoprost | 13 | $274 | $21 |
2016: 1 drug
| Latanoprost | 13 | $182 | $14 |
2014: 1 drug
| Latanoprost | 14 | $126 | $9 |
Money from drug and device companies
$43 in 2020
| 2020 | 2 | 3 | None | $43 |
| 2019 | 5 | 9 | None | $460 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sun Pharmaceutical Industries | Cequa | $30 | 2 payments
|
| Johnson & Johnson Vision Care | Acuvue | $13 | 1 payment
|
See all 3 published payments
| Johnson & Johnson Vision Care | Meals · 2020-07-02 | Acuvue | $13 |
| Sun Pharmaceutical Industries | Meals · 2020-02-06 | Cequa | $18 |
| Sun Pharmaceutical Industries | Meals · 2020-02-05 | Cequa | $12 |
See earlier years (2019)
2019: $460
| MacuLogix | Adaptdx | $185 | 1 payment
|
| Sight Sciences | Tearcare | $125 | 1 payment
|
| Alcon Vision | Dailies | $83 | 4 payments
|
| Johnson & Johnson Vision Care | Acuvue | $42 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Ultra | $25 | 1 payment
|
Professional record
- NPI
- 1407911282
- Licence
- CA 12826T
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 130 S Sunnyvale Ave, Sunnyvale, CA, 94086
- NPI first listed
- 2006-12-22
- NPI last updated
- 2021-12-30
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.